Colossal (Series A)
Funding Details
- Awarder
- Gaingels
- Date Award
- May 24, 2024
- Vertical
- Healthcare and Biotech
- Funding URL
- View Funding Page
- Valuation
- $1,300,000,000,000
Company Info
- Founders
- Ben Lamm
- Company Description
- Colossal is combining the science of genetics with the business of discovery to build the world’s first de-extinction and species preservation company and more broadly advance economies of biology and healing through genetics. Colossal is a bioscience and genetic engineering company that focuses on de-extinction of past species.
- Market
- Healthcare & Wellness
- Coinvestors
- At One Ventures, L.P.